Skip to main content

2015 to 2021 Saw Increase in Gabapentinoid Use

Medically reviewed by Carmen Pope, BPharm. Last updated on Jan 24, 2024.

By Lori Solomon HealthDay Reporter

TUESDAY, Jan. 23, 2024 -- Use of gabapentinoids has increased since 2015, particularly for chronic pain, according to a study published in the January/February issue of the Annals of Family Medicine.

Michael E. Johansen, M.D., from OhioHealth in Columbus, and Donovan T. Maust, M.D., from University of Michigan in Ann Arbor, used the 2002-2021 Medical Expenditure Panel Survey to characterize gabapentinoid use in the adult population, including the ages of users; associated medications and diagnoses; and the likelihood of starting, stopping, or continuing gabapentinoids.

The researchers found that gabapentinoid users continued to increase from 4.0 percent in 2015 to 4.7 percent in 2021. Among individuals who used other medications for chronic pain, gabapentinoid use was much more likely. Numerous chronic pain conditions were associated with gabapentinoid use, despite minimal evidence to support this off-label use. The number of new gabapentinoid users clearly outnumbered gabapentinoid stoppers between 2011-2012 and 2017-2018, although this difference declined in the most recent cohorts.

"Gabapentinoids continue to be commonly used in conjunction with other sedating medications, which is concerning in light of the U.S. Food and Drug Administration’s 2019 warning about coprescribing of gabapentinoids with other central nervous system depressants," the authors write.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Read this next

Factors Identified for Integrative Health and Medicine Use in Chronic Pain

MONDAY, Feb. 12, 2024 -- Factors associated with engagement in integrative health and medicine (IHM) and nonpharmacologic modalities versus opioids have been identified for adults...

2002 to 2022 Saw Increased Use of Complementary Health by U.S. Adults

WEDNESDAY, Feb. 7, 2024 -- Between 2002 and 2022, U.S. adults significantly increased use of complementary health approaches (CHAs), including for pain management, according to a...

Medical Cannabis Use for Chronic Pain Linked to New-Onset Arrhythmia

FRIDAY, Jan. 12, 2024 -- For patients with chronic pain, medical cannabis use is associated with an increased risk for new-onset arrhythmia, according to a study published online...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.